Trial Profile
Posaconazole for the treatment of fungal infections (IFI) in acute leukemia (AL) patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2018
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Adverse reactions; Therapeutic Use
- 08 Nov 2018 New trial record
- 07 Oct 2018 Results assessing invasive fungal infections (IFI) in acute leukemia (AL) patients with treatment of posaconazole, presented at the IDWeek 2018.